These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12960646)

  • 1. Immunogenicity and safety of hepatitis A vaccine in children with chronic liver disease.
    Ferreira CT; da Silveira TR; Vieira SM; Taniguchi A; Pereira-Lima J
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):258-61. PubMed ID: 12960646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of an inactivated hepatitis A vaccine in children with Down syndrome.
    Ferreira CT; Leite JC; Taniguchi A; Vieira SM; Pereira-Lima J; da Silveira TR
    J Pediatr Gastroenterol Nutr; 2004 Oct; 39(4):337-40. PubMed ID: 15448421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of hepatitis A vaccine in children with celiac disease.
    Sari S; Dalgic B; Basturk B; Gonen S; Soylemezoglu O
    J Pediatr Gastroenterol Nutr; 2011 Nov; 53(5):532-5. PubMed ID: 21587080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.
    Beck BR; Hatz CF; Loutan L; Steffen R
    J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine in healthy children in India.
    Jain H; Kumavat V; Singh T; Versteilen A; Sarnecki M
    Hum Vaccin Immunother; 2014; 10(7):2089-97. PubMed ID: 25424821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
    Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
    Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing live attenuated and inactivated hepatitis A vaccines: an immunogenicity study after one single dose.
    Zheng H; Chen Y; Wang F; Gong X; Wu Z; Miao N; Zhang X; Li H; Chen C; Hou X; Cui F; Wang H
    Vaccine; 2011 Nov; 29(48):9098-103. PubMed ID: 21875638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of a new inactivated hepatitis A vaccine in young adults: a comparative study.
    Ren A; Feng F; Ma J; Xu Y; Liu C
    Chin Med J (Engl); 2002 Oct; 115(10):1483-5. PubMed ID: 12490092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up study.
    Yu C; Song Y; Qi Y; Li C; Jiang Z; Li C; Zhang W; Wang L; Xia J
    Hum Vaccin Immunother; 2016 Oct; 12(10):2595-2602. PubMed ID: 27385349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
    Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
    Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.
    Liu XE; Wushouer F; Gou A; Kuerban M; Li X; Sun Y; Zhang J; Liu Y; Li J; Zhuang H
    Hum Vaccin Immunother; 2013 Jul; 9(7):1460-5. PubMed ID: 23571173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
    Dagan R; Amir J; Livni G; Greenberg D; Abu-Abed J; Guy L; Ashkenazi S; Foresner G; Tewald F; Schätzl HM; Hoffmann D; Ibanez R; Herzog C
    Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated hepatitis a vaccine in children.
    Mitra M; Shah N; Faridi M; Ghosh A; Sankaranarayanan VS; Aggarwal A; Chatterjee S; Bhattacharyya N; Kadhe G; Vishnoi G; Mane A
    Hum Vaccin Immunother; 2015; 11(5):1147-52. PubMed ID: 26018443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
    Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of hepatitis A vaccine in children with chronic liver disease.
    El-Karaksy HM; El-Hawary MI; El-Koofy NM; El-Sayed R; El-Raziky MA; Mansour SA; Taha GM; El-Mougy F
    World J Gastroenterol; 2006 Dec; 12(45):7337-40. PubMed ID: 17143952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenecity of hepatitis A vaccine in pediatric patients with inflammatory bowel disease.
    Radzikowski A; Banaszkiewicz A; Łazowska-Przeorek I; Grzybowska-Chlebowczyk U; Woś H; Pytrus T; Iwańczak B; Kowalska-Duplaga K; Fyderek K; Gawrońska A; Karolewska-Bochenek K; Kotowska M; Albrecht P
    Inflamm Bowel Dis; 2011 May; 17(5):1117-24. PubMed ID: 20818674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.